Literature DB >> 355912

The quantitative assessment of lipofuscin pigment, cytoplasmic RNA and nucleolar volume in senile dementia.

D M Mann, K G Sinclair.   

Abstract

Treatment of patients suffering from senile dementia with meclofenoxate has been reported to result in an improvement in mental performance. Furthermore meclofenoxate reduces the amount of lipofuscin pigment in nerve cells. We have shown that, although nerve cells in a group of demented patients have decreased amounts of cytoplasmic RNA and reduced nucleolar volume, they contain no more pigment than do cells of a control group. It seems, therefore, unlikely that removal of lipofuscin, per se, has any bearing on this reported improvement in intellectual capability, nor is it implicated in the aetiology of senile dementia.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 355912     DOI: 10.1111/j.1365-2990.1978.tb00553.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  6 in total

1.  Aluminum, altered transcription, and the pathogenesis of Alzheimer's disease.

Authors:  D R Crapper McLachlan; W J Lukiw; T P Kruck
Journal:  Environ Geochem Health       Date:  1990-03       Impact factor: 4.609

2.  Alterations in protein synthetic capability of nerve cells in Alzheimer's disease.

Authors:  D M Mann; D Neary; P O Yates; J Lincoln; J S Snowden; P Stanworth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-02       Impact factor: 10.154

3.  Relationship between pigment accumulation and age in Alzheimer's disease and Down syndrome.

Authors:  D M Mann; P O Yates; B Marcyniuk
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  Molecular cloning of amyloid cDNA derived from mRNA of the Alzheimer disease brain: coding and noncoding regions of the fetal precursor mRNA are expressed in the cortex.

Authors:  S B Zain; M Salim; W G Chou; E M Sajdel-Sulkowska; R E Majocha; C A Marotta
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  Polyadenylated messenger RNA in paired helical filament-immunoreactive neurons in Alzheimer disease.

Authors:  W S Griffin; C Ling; C L White; M Morrison-Bogorad
Journal:  Alzheimer Dis Assoc Disord       Date:  1990       Impact factor: 2.703

Review 6.  Tau-mediated dysregulation of RNA: Evidence for a common molecular mechanism of toxicity in frontotemporal dementia and other tauopathies.

Authors:  Shon A Koren; Sara Galvis-Escobar; Jose F Abisambra
Journal:  Neurobiol Dis       Date:  2020-05-12       Impact factor: 5.996

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.